Page last updated: 2024-10-17

n(1)-acetylspermidine and Parkinson Disease

n(1)-acetylspermidine has been researched along with Parkinson Disease in 1 studies

N(1)-acetylspermidine : An acetylspermidine having the acetyl group at the N1-position.

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Paik, MJ1
Ahn, YH1
Lee, PH1
Kang, H1
Park, CB1
Choi, S1
Lee, G1

Other Studies

1 other study available for n(1)-acetylspermidine and Parkinson Disease

ArticleYear
Polyamine patterns in the cerebrospinal fluid of patients with Parkinson's disease and multiple system atrophy.
    Clinica chimica acta; international journal of clinical chemistry, 2010, Oct-09, Volume: 411, Issue:19-20

    Topics: Aged; Biomarkers; Cerebrospinal Fluid; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; M

2010